Current prevalence of chronic hepatitis B and C virus infection in the general population, blood donors and pregnant women in the EU/EEA: a systematic review, Epidemiol Infect, vol.145, issue.14, pp.2873-85, 2017. ,
The global burden of viral hepatitis from 1990 to 2013: findings from the Global Burden of Disease Study, The Lancet, vol.388, pp.1081-1089, 2013. ,
Hepatitis C virus (HCV) genotypes distribution: an epidemiological up-date in Europe, Infect Agent Cancer, vol.11, p.53, 2016. ,
, European Centre for Disease Prevention and Control. Hepatitis C In: ECDC. Annual epidemiological report for, 2016.
, World Health Organization. Global health sector strategy on viral hepatitis 2016-2021 towards ending viral hepatitis. Geneva: World Health Organization, 2016.
, Action plan for the health sector response to viral hepatitis in the WHO European Region. Geneva: World Health Organization, 2016.
Roundtable discussion: how lessons learned from HIV can inform the global response to viral hepatitis, BMC Infect Dis, vol.14, 2014. ,
World Hepatitis Day 2013: Know it, Confront it. The Lancet Global Health, vol.1, p.70038, 2013. ,
The Role of Civil Society Organizations in Monitoring the Global AIDS Response, AIDS Behav, vol.21, issue.1, p.27734168, 2017. ,
Monitoring HIV-Related Laws and Policies: Lessons for AIDS and Global Health in Agenda 2030, AIDS Behav, vol.21, issue.1, p.28084561, 2017. ,
Hep-CORE: a crosssectional study of the viral hepatitis policy environment reported by patient groups in 25 European countries in 2016 and 2017, J Int AIDS Soc, vol.21, issue.2, p.25052, 2018. ,
, Hep-Core report. Monitoring the implementation of hepatitis B and C policy recommendations in Europe, European Liver Patients Associtation. The, 2016.
Restrictions on access to direct-acting antivirals for people who inject drugs: The European Hep-CORE study and the role of patient groups in monitoring national HCV responses, Int J Drug Policy, vol.47, pp.47-50, 2017. ,
Accelerating the elimination of viral hepatitis: a, Lancet Gastroenterology & Hepatology Commission. The Lancet Gastroenterology & Hepatology, vol.4, issue.2, pp.135-84, 2019. ,
A technique for the measurement of attitudes, Archives of Psychology, vol.22, p.16, 1932. ,
Harm reduction and viral hepatitis C in European prisons: a cross-sectional survey of 25 countries, Harm Reduct J, vol.15, issue.1, p.29751763, 2018. ,
The removal of DAA restrictions in Europe-One step closer to eliminating HCV as a major public health threat, J Hepatol, vol.69, issue.5, pp.1188-96, 2018. ,
Restrictions for reimbursement of interferon-free direct-acting antiviral drugs for HCV infection in Europe, The Lancet Gastroenterology & Hepatology, vol.3, issue.2, pp.125-158, 2018. ,
, Country drug reports: European Monitoring Center for Drugs and Drug Additction, 2018.
Multiple correspondence analysis: one only or several techniques?, Quality & Quantity, vol.50, issue.3, pp.1299-315, 2015. ,
Correspondence analysis is a useful tool to uncover the relationships among categorical variables, J Clin Epidemiol, vol.63, issue.6, pp.638-684, 2010. ,
Correspondence analysis in practice, vol.3, 2017. ,
Methods For Constructing Composite Indices: One For All Or All For One? Rivista Italiana di, Economia Demografia e Statistica, vol.67, issue.2, 2013. ,
Micro-elimination-A path to global elimination of hepatitis C, Journal of hepatology, vol.67, issue.4, pp.665-671, 2017. ,
The micro-elimination approach to eliminating hepatitis C: strategic and operational considerations, Seminars in liver disease, 2018. ,
Weights and importance in composite indicators: Closing the gap, Ecol Indic, vol.80, pp.12-22, 2017. ,
Do the most heavily burdened countries have the right policies to eliminate viral hepatitis B and C, Lancet Gastroenterology and Hepatology, 2020. ,
Ratings and rankings: voodoo or science, Journal of the Royal Statistical Society, vol.176, p.24, 2013. ,